Labstat Inc., a Certified Group company and the world’s largest independent nicotine testing laboratory, has appointed Scott LaNeve as its new president. LaNeve brings more than three decades of leadership experience in life sciences, diagnostics and healthcare technology, including senior roles at Abbott Laboratories, Roche Diagnostics and Quest Diagnostics, as well as executive posts in national laboratory networks and technology firms.

In announcing the appointment, LaNeve said he was honored to join Labstat, which operates laboratories in Canada, the U.S. and Europe focused on nicotine, tobacco and cannabis testing. He stressed his commitment to advancing Labstat’s role in global tobacco harm reduction by providing trusted testing and actionable, data-driven insights to clients.

Certified Group CEO David Morgan welcomed the hire, pointing to LaNeve’s strategic vision and operational expertise as central to reinforcing Labstat’s leadership worldwide.

This article was adapted from an original report published on tobaccoreporter.com. All rights belong to the original publisher.